Position in RCEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,118
-$6,804 QoQ
Shares Held
755
-71.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 73 holders
Holding Since
Mar 2022
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RCEL Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $1,820,800,481 across 112 Medical Devices names. RCEL ranks #88 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDT |
Medtronic plc
|
6,084,725 | $476,008,034 | |
| 2 | ABT |
Abbott Laboratories
|
3,863,474 | $350,571,627 | |
| 3 | SYK |
Stryker Corp
|
805,637 | $253,646,750 | |
| 4 | BSX |
Boston Scientific Corp
|
4,584,260 | $195,656,215 | |
| 5 | BIO |
Bio-Rad Laboratories, Inc.
|
267,634 | $78,580,018 | |
| 6 | EW |
Edwards Lifesciences Corp
|
775,100 | $70,115,545 | |
| 7 | DXCM |
Dexcom Inc
|
999,563 | $67,320,565 | |
| 8 | GEHC |
GE HealthCare Technologies Inc.
|
913,578 | $58,478,126 |
All Filings in RCEL
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,118 | 755 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $9,922 | 2,682 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $65,808 | 19,075 | Shares | Sole | 2026-02-13 | |
| 2025-06-30 | $246,296 | 46,559 | Shares | Sole | 2026-02-27 | |
| 2022-06-30 | $427 | 90 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $33,445 | 3,944 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||